AUTOLOGOUS BLOOD INJECTION FOR TREATMENT OF CHRONIC RECURRENT TMJ DISLOCATION

Abstract

Background-Whenever the condyle crosses the articular eminence and travels far anteriorly during opening, the temporomandibular joint (TMJ) becomes dislocated. An intra-articular effusion then frequently stretches the ligaments surrounding the joint, resulting in excruciating pain, difficulties speaking and eating, and spasms in the muscles surrounding the joint.

Methodology: Thirty individuals who had recurrent chronic total joint dislocation were split into two groups of equal size at random (15 participants each). The second group got autologous blood infusions to the two pericapsular tissues (PT) and the superior joint space (SJS), while Group A received just autologous blood infusions to the SJS.

Results: The present investigation's findings at the completion of the one-year follow-up phase indicated that injecting autologous blood into both the PT and the SJS had a higher success rate (80%) than injecting it into the SJS alone (60%). Additionally, the B in cohort individuals' optimum mouth opening decreased on average by 5.3 +/- 2.1, compared to group A participants' 3.6 +/- 1.5. Additionally, as opposed to being anterior to the articular eminence prior to the injection, the condylar head was only visible posterior to it in its open state on the computerised radiography imaging of the joints in group B. No detrimental alterations to the joint's skeletal elements have been seen in either cohort.

Conclusions: The research presented here suggests that injecting autologous blood into the TMJ of patients experiencing recurrent chronic dislocations is a straightforward, secure, and economical procedure.